- About Us
- Clinical Trials
Available Clinical Trials
- Resources
- Contact Us
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
LU002 is permanently closed to accrual, effective December 6, 2023.